Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...
Dawn4d
Petition filed in IHC for recovery of US-based journalist Ahmad Noorani’s 2 brothers
Investigative journalist Ahmad Noorani’s mother petitioned the Islamabad High Court on Wednesday for the recovery of his two ...
DriveSpark4d
Genesis Inspiration Foundation Invests In STEAM And Arts Education For Youth In Florida
Genesis Inspiration Foundation invests $50,000 in Breakthrough Miami to support STEAM and arts education for youth in Florida ...
Anti-HER2 Biparatopic ADC JSKN003 Has Been Granted Breakthrough-Therapy Designation for the Treatment of PROC
Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has ...